NLRP3 and chronic obstructive pulmonary disease: The strategy of suppressing pyroptosis by inhibiting NLRP3 inflammasome activation, blocking inflammatory caspase maturation, and preventing GSDMD cleavage offers a promising therapeutic approach for COPD (Table 5).